| 0.40 | 1.02% |
| SLXP NASDAQSalix Pharmaceuticals Ltd. | |
Market Cap 2.284B Book Value 6.472 EBITDA -12.0M PEG Ratio 29.94 EPS -1.178 P/B Ratio 6.04 Short Ratio 6.50 Index Membership S&P Sector Healthcare Full Time Employees 395 Profile Get Profile for: Drug Related Products Open 39.06 High 39.58 Low 38.98 Volume 178.9 K Target Price 50.60 Current EPS -1.178 This Year EPS 0.03 Next Year EPS 1.55 This Year PE 1303.33 Next Year PE 25.23 | Symbol | SLXP | | Name | Salix Pharmaceuticals Ltd. | | Type | Stock | | Country | United States | | Exchange | NASDAQ |
| | Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. |
Company Summary more  Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or shor... Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or short-term therapy for adults; Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis; Anusol-HC and Proctocort, the hydrocortisone creams and suppositories for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and inflammatory conditions; Pepcid and Diuril oral suspensions, which are used for gastrointestinal indications that include the treatment of duodenal ulcer, benign gastric ulcer, and gastro esophageal reflux diseases; and Colazal capsules for the treatment of ulcerative colitis. In addition, Salix has products under development for the treatment of hepatic encephalopathy and irritable bowel syndrome, HIV-associated diarrhea, gastroenterology, and ulcerative proctitis or proctosigmoiditis. It has collaboration agreements with aaiPharma LLC; Alfa Wassermann S.P.A.; Biorex Laboratories Limited; Cedars?Sinai Medical Center; Clinical Development Capital Partnership; Dr. Falk Pharma GmbH; King Pharmaceuticals, Inc.; Lupin, Ltd.; Merck & Co., Inc.; Napo Pharmaceuticals, Inc.; Norgine B.V.; and Wilmington Pharmaceuticals, LLC. The company was founded in 1989 and is headquartered in Morrisville, North Carolina. Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or shor... Top Stories| | 2010-08-31 |  | |
| | |
Earnings Postmortem for NBTY; NTY, PRGO, SLXP, HLF
Learning Markets - Aug 31, 2010
NBTY, Inc. (NTY) [Chart - Analysis - News] released its most recent earnings statement about a month ago on Wednesday, July 28th. NBTY, Inc. beat expectations with a profit of $1.03 per share---21 ...
2010-08-31 |  | |
| | | 2010-08-30 |  | |
| | | 2010-08-30 |  | |
|
| | A rally among airlines and a surprise jump in factory orders pushed US stocks higher in choppy trading on Tuesday. 2010-09-02 |  | |
|
Community Discussions | | | (0.08) | 0.14% |
| HLF NYSEHerbalife Ltd. | |
Market Cap 3.332B Book Value 6.669 EBITDA 410.7M PEG Ratio 1.00 EPS 3.921 P/E 14.38 P/B Ratio 8.45 Short Ratio 2.70 Sector Healthcare Full Time Employees 4,100 Profile Get Profile for: Drug Related Products Open 56.50 High 56.75 Low 56.30 Volume 152 K Target Price 68.17 Current EPS 3.921 This Year EPS 4.42 Next Year EPS 5.03 Current PE 14.38 This Year PE 12.76 Next Year PE 11.21 Dividend 0.85 Dividend Yield 1.51 Dividend Date Aug 26 | Symbol | HLF | | Name | Herbalife Ltd. | | Type | Stock | | Country | United States | | Exchange | NYSE |
| | Herbalife Ltd., a network marketing company, sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. |
Company Summary more  Herbalife Ltd., a network marketing company, sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. It offers science based products in four principal categories: weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. The company?s weight management product portfolio includes meal replacement shakes, weight-loss enhancers, appetite suppressors, and a range of healthy snacks. Its targeted nutrition products comprise dietary supplements, which contain herbs, vitamins, minerals, and natural ingredients that support good health. The company?s energy, sports, and fitness products consist of energy and is... Herbalife Ltd., a network marketing company, sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. It offers science based products in four principal categories: weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. The company?s weight management product portfolio includes meal replacement shakes, weight-loss enhancers, appetite suppressors, and a range of healthy snacks. Its targeted nutrition products comprise dietary supplements, which contain herbs, vitamins, minerals, and natural ingredients that support good health. The company?s energy, sports, and fitness products consist of energy and isotonic drinks to support a healthy active lifestyle. Its outer nutrition products include skin cleansers, toners, moisturizers and facial masks, shampoos and conditioners, anti-aging products, body-wash items, and a selection of fragrances for men and women. The company also sells literature and promotional materials, including sales aids, informational audiotapes, videotapes, CDs, and DVDs designed to support its distributors? marketing efforts, as well as start-up kits for new distributors. It sells its products through a network of independent distributors, as well as through its retail stores and sales force in China. The company was founded in 1980 and is based in Grand Cayman, Cayman Islands. Herbalife Ltd., a network marketing company, sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. It offers science based products in four principal categories: weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. The company?s weight management product portfolio includes meal replacement shakes, weight-loss enhancers, appetite suppressors, and a range of healthy snacks. Its targeted nutrition products comprise dietary supplements, which contain herbs, vitamins, minerals, and natural ingredients that support good health. The company?s energy, sports, and fitness products consist of energy and is... Top Stories| | 2010-09-01 |  | |
| | | 2010-09-01 |  | |
| | | 2010-09-01 |  | |
| | |
Zacks.com featured expert Kevin Matras highlights: Ballantyne Strong, Inc., Herbalife Ltd., iGATE Corp., Quaker Chemical Corp. and Compania Cervecerias Unidas SA
Zacks.com - Aug 31, 2010
Chicago, IL ? August 31, 2010 - Stocks in this week's article include Ballantyne Strong, Inc. (AMEX: BTN - Snapshot Report), Herbalife Ltd. (NYSE: HLF - Snapshot Report), iGATE Corp. (NASDAQ: IGTE ...
2010-08-31 |  | |
|
Community Discussions |